Long Term Safety Study of NVA237 vs QAB149 in COPD Patients
Public ClinicalTrials.gov record NCT01697696. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, 52-week Study to Assess the Safety of NVA237 Compared to QAB149 in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Have Moderate to Severe Airflow Limitation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to provide long term safety data of NVA237. This study will assess the safety and tolerability of a single dose strength of NVA237.
Study identification
- NCT ID
- NCT01697696
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 511 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2012 (Type not available)
- Primary completion
- Nov 2014 (Actual)
- Completion
- Nov 2014 (Actual)
- Last update posted
- Mar 16, 2016
2012 – 2014
United States locations
- U.S. sites
- 61
- U.S. states
- 27
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Gulf Shores | Alabama | 36547 | — |
| Novartis Investigative Site | Mobile | Alabama | 36608 | — |
| Novartis Investigative Site | Tucson | Arizona | 85712 | — |
| Novartis Investigative Site | Riverside | California | 92506 | — |
| Novartis Investigative Site | Fort Collins | Colorado | 80528 | — |
| Novartis Investigative Site | Wheat Ridge | Colorado | 80033 | — |
| Novartis Investigative Site | Glastonbury | Connecticut | 06033 | — |
| Novartis Investigative Site | Stamford | Connecticut | 06902 | — |
| Novartis Investigative Site | Waterbury | Connecticut | 06708 | — |
| Novartis Investigative Site | Clearwater | Florida | 33765 | — |
| Novartis Investigative Site | Hialeah | Florida | 33016 | — |
| Novartis Investigative Site | Miami | Florida | 33165 | — |
| Novartis Investigative Site | Miami | Florida | 33172 | — |
| Novartis Investigative Site | Miami | Florida | 33175 | — |
| Novartis Investigative Site | Oakland Park | Florida | 33334 | — |
| Novartis Investigative Site | Pensacola | Florida | 32503 | — |
| Novartis Investigative Site | Couer D'Alene | Idaho | 83814 | — |
| Novartis Investigative Site | Newburgh | Indiana | 47630 | — |
| Novartis Investigative Site | Topeka | Kansas | 66606 | — |
| Novartis Investigative Site | Florence | Kentucky | 41042 | — |
| Novartis Investigative Site | Madisonville | Kentucky | 42431 | — |
| Novartis Investigative Site | New Orleans | Louisiana | 70119 | — |
| Novartis Investigative Site | Opelousas | Louisiana | 70570 | — |
| Novartis Investigative Site | Biddeford | Maine | 04005 | — |
| Novartis Investigative Site | Worchester | Massachusetts | 01608 | — |
| Novartis Investigative Site | Edina | Minnesota | 55435 | — |
| Novartis Investigative Site | Fridley | Minnesota | 55432 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55402 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55407 | — |
| Novartis Investigative Site | Fremont | Nebraska | 68025 | — |
| Novartis Investigative Site | Omaha | Nebraska | 68134 | — |
| Novartis Investigative Site | Henderson | Nevada | 89014 | — |
| Novartis Investigative Site | Las Vegas | Nevada | 89119 | — |
| Novartis Investigative Site | Lebanon | New Hampshire | 03756 | — |
| Novartis Investigative Site | Calabash | North Carolina | 28467 | — |
| Novartis Investigative Site | Tabor City | North Carolina | 28463 | — |
| Novartis Investigative Site | Columbus | Ohio | 43215 | — |
| Novartis Investigative Site | Columbus | Ohio | 43235 | — |
| Novartis Investigative Site | Marion | Ohio | 43302 | — |
| Novartis Investigative Site | Zanesville | Ohio | 43701 | — |
| Novartis Investigative Site | Eugene | Oregon | 97404-3233 | — |
| Novartis Investigative Site | Philadelphia | Pennsylvania | 19140 | — |
| Novartis Investigative Site | Warwick | Rhode Island | 02886 | — |
| Novartis Investigative Site | Charleston | South Carolina | 29412 | — |
| Novartis Investigative Site | Columbia | South Carolina | 29204 | — |
| Novartis Investigative Site | Greenville | South Carolina | 29605 | — |
| Novartis Investigative Site | Greer | South Carolina | 29651 | — |
| Novartis Investigative Site | North Myrtle Beach | South Carolina | 29582 | — |
| Novartis Investigative Site | Boerne | Texas | 78006 | — |
| Novartis Investigative Site | El Paso | Texas | 79902 | — |
| Novartis Investigative Site | Houston | Texas | 77043 | — |
| Novartis Investigative Site | Houston | Texas | 77081 | — |
| Novartis Investigative Site | Kingwood | Texas | 77339 | — |
| Novartis Investigative Site | San Antonio | Texas | 78229 | — |
| Novartis Investigative Site | White River Junction | Vermont | 05009 | — |
| Novartis Investigative Site | Burke | Virginia | 22015 | — |
| Novartis Investigative Site | Fredericksburg | Virginia | 22401 | — |
| Novartis Investigative Site | Manassas | Virginia | 20110 | — |
| Novartis Investigative Site | Richmond | Virginia | 23225 | — |
| Novartis Investigative Site | Richmond | Virginia | 23229 | — |
| Novartis Investigative Site | Oregon | Wisconsin | 53575 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01697696, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 16, 2016 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01697696 live on ClinicalTrials.gov.